Impact of Immune Checkpoint Inhibitors

episode

Neurology® Podcast not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

recent transcribed audio

Full Show Podcast: 23 September 2026 1h 29m · 22 Sep 2026 · The Mike Hosking Breakfast

Evening Wire: Trump Delivers Remarks to the UN & Nolan Wells Drowning Updates | 9.22.26 11 min · 22 Sep 2026 · Morning Wire

🎙Tell us your Group Chat Names - The Chat 10 min · 22 Sep 2026 · The Hauraki Breakfast Podcast

MORNING TEA: Taylor Swift's Surprise New Single & William and Kate Hit The Red Carpet With Tom Cruise 7 min · 22 Sep 2026 · The Spill

Trump Touts Foreign Policy Vision in UN Speech Ahead of Midterms 13 min · 22 Sep 2026 · WSJ What’s News

Andrew Fairgray: 2degrees Chief Business Officer on the company posting a $1.46 billion profit 3 min · 22 Sep 2026 · The Mike Hosking Breakfast

Report any issue

Source

Recorded04 Apr 2024

Publisherneurology.libsyn.com ↗

Handlerec:5447477

Show notes

Dr. Justin Abbatemarco talks with Dr. Géraldine Androdias about the impact of immune checkpoint inhibitors on the course of multiple sclerosis. Read the related article in Neurology: Neuroimmunology and Neuroinflammation. Disclosures can be found at Neurology.org.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related